Says orthopedic spine surgeon Bob Eastlack, MD I was first introduced to Carevature's concept several years ago. To see the various Dreal models fully developed and have them available to me in treating patients suffering from lumbar spinal stenosis and other degenerative spine conditions, gives me new minimally invasive options in the operating room.
According to Carevature, Dreal technology allows surgeons to effectively target the impinging bone causing pain, and to preserve the soft tissue and bone critical to the patient's spinal stability. This technology also has significant potential to prevent more extensive fusion surgery.
To date, Carevature Medical's Dreal technology has assisted surgeons in over 1,500 cases, both non-fusion and fusion. The company's highly targeted approach has it working with medical systems and surgeons located across the US, in Chicago, Boston, Dallas, southern California, Michigan, Tennessee, and Florida, with plans to expand throughout 2019 and 2020.